Ana Milinkovic
- Virology top 1%
- HIV Research and Treatment 34
- Emergency Medicine top 0.5%
- HIV-related health complications and treatments 41
- Hepatology top 1%
- Hepatitis C virus research 9
- Infectious Diseases top 1%
- HIV/AIDS drug development and treatment 37
- HIV/AIDS Research and Interventions 25
- Epidemiology top 5%
- Liver Disease Diagnosis and Treatment 8
- Hepatitis B Virus Studies 5
-
- Bone and Joint Diseases 5
- Co-authors
- Estebán MartínezJosep MallolasJosé Luís BlancoElisa de LazzariMaría LarrousseAgathe LeónJosé M. GatellMontserrat Loncà
- Cited by
- VirologyEmergency MedicineHepatology
- Partner nations
- SpainUnited KingdomItaly
In The Last Decade
Ana Milinkovic
65 papers receiving 2.2k citations
Peers
Comparison fields: 5 of 113
- Virology 771
- Emergency Medicine 890
- Hepatology 664
- Infectious Diseases 1.4k
- Epidemiology 818
Countries citing papers authored by Ana Milinkovic
This map shows the geographic impact of Ana Milinkovic's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ana Milinkovic with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ana Milinkovic more than expected).
Fields of papers citing papers by Ana Milinkovic
This network shows the impact of papers produced by Ana Milinkovic. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ana Milinkovic. The network helps show where Ana Milinkovic may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Ana Milinkovic, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 1 | |
| 3 | 2024 | 7 | |
| 4 | 2024 | 2 | |
| 5 | 2023 | 1 | |
| 6 | A phase IV, open-label three-arm study investigating the impact of a combination of tenofovir disoproxil fumarate/emtricitabine with raltegravir or dolutegravir or elvitegravir/cobicistat on renal function in HIV-1 antiretroviral naïve patients. | 2021 | 0 |
| 7 | 2019 | 9 | |
| 8 | 2019 | 41 | |
| 9 | 2019 | 9 | |
| 10 | 2015 | 14 | |
| 11 | 2008 | 12 | |
| 12 | 2008 | 8 | |
| 13 | 2007 | 29 | |
| 14 | 2007 | 60 | |
| 15 | 2006 | 18 | |
| 16 | 2005 | 156 | |
| 17 | 2005 | 8 | |
| 18 | 2005 | 39 | |
| 19 | 2004 | 49 | |
| 20 | 2004 | 62 |
About Ana Milinkovic
Ana Milinkovic is a scholar working on Virology, Emergency Medicine and Infectious Diseases, having authored 70 papers that have together received 2.3k indexed citations. Recurring topics across this work include HIV-related health complications and treatments (41 papers), HIV/AIDS drug development and treatment (37 papers), HIV Research and Treatment (34 papers), HIV/AIDS Research and Interventions (25 papers), Hepatitis C virus research (9 papers), Liver Disease Diagnosis and Treatment (8 papers), Bone and Joint Diseases (5 papers) and Hepatitis B Virus Studies (5 papers). The work is most often cited by research in Virology (771 citations), Emergency Medicine (890 citations) and Hepatology (664 citations). Ana Milinkovic has collaborated with scholars based in Spain, United Kingdom and Italy. Frequent co-authors include Estebán Martínez, Josep Mallolas, José Luís Blanco, Elisa de Lazzari, María Larrousse, Agathe León, José M. Gatell, Montserrat Loncà, Montserrat Laguno and Óscar Miró.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.